Zimmer Biomet Holdings Inc logo

Zimmer Biomet Holdings Inc

LTS:0QQD (USA)  
CHF 136.12 (0%) Apr 24
24.78
P/B:
2.00
Market Cap:
CHF 22.70B ($ 24.85B)
Enterprise V:
CHF 27.71B ($ 30.34B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Zimmer Biomet Holdings Inc ( ) from 2014 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Zimmer Biomet stock (LTS:0QQD) PE ratio as of Apr 25 2024 is 24.78. More Details

Zimmer Biomet Holdings Inc (LTS:0QQD) PE Ratio (TTM) Chart

To

Zimmer Biomet Holdings Inc (LTS:0QQD) PE Ratio (TTM) Historical Data

Total 1257
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Zimmer Biomet PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-25 31.2 2024-02-21 31.2
2024-04-24 31.2 2024-02-20 31.2
2024-04-23 31.2 2024-02-19 31.2
2024-04-22 31.2 2024-02-16 31.2
2024-04-19 31.2 2024-02-15 31.2
2024-04-18 31.2 2024-02-14 31.2
2024-04-17 31.2 2024-02-13 31.2
2024-04-16 31.2 2024-02-12 31.2
2024-04-15 31.2 2024-02-09 31.2
2024-04-12 31.2 2024-02-08 31.2
2024-04-11 31.2 2024-02-07 31.2
2024-04-10 31.2 2024-02-06 31.2
2024-04-09 31.2 2024-02-05 31.2
2024-04-08 31.2 2024-02-02 31.2
2024-04-05 31.2 2024-02-01 31.2
2024-04-04 31.2 2024-01-31 31.2
2024-04-03 31.2 2024-01-30 31.2
2024-04-02 31.2 2024-01-29 31.2
2024-03-29 31.2 2024-01-26 31.2
2024-03-28 31.2 2024-01-25 31.2
2024-03-27 31.2 2024-01-24 31.2
2024-03-26 31.2 2024-01-23 31.2
2024-03-25 31.2 2024-01-22 31.2
2024-03-22 31.2 2024-01-19 31.2
2024-03-21 31.2 2024-01-18 31.2
2024-03-20 31.2 2024-01-17 31.2
2024-03-19 31.2 2024-01-16 31.2
2024-03-18 31.2 2024-01-15 31.2
2024-03-15 31.2 2024-01-12 31.2
2024-03-14 31.2 2024-01-11 31.2
2024-03-13 31.2 2024-01-10 31.2
2024-03-12 31.2 2024-01-09 31.2
2024-03-11 31.2 2024-01-08 31.2
2024-03-08 31.2 2024-01-05 31.2
2024-03-07 31.2 2024-01-04 31.2
2024-03-06 31.2 2024-01-03 31.2
2024-03-05 31.2 2024-01-02 31.2
2024-03-04 31.2 2024-01-01 31.2
2024-03-01 31.2 2023-12-29 31.2
2024-02-29 31.2 2023-12-28 31.2
2024-02-28 31.2 2023-12-27 66.7
2024-02-27 31.2 2023-12-25 66.7
2024-02-26 31.2 2023-12-22 66.7
2024-02-23 31.2 2023-12-21 66.7
2024-02-22 31.2 2023-12-20 66.7

Zimmer Biomet Holdings Inc (LTS:0QQD) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.